145 related articles for article (PubMed ID: 34677707)
1. Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study.
Miyazaki C; Ishii Y; Stelmaszuk NM
Clin Rheumatol; 2022 Mar; 41(3):741-755. PubMed ID: 34677707
[TBL] [Abstract][Full Text] [Related]
2. Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population.
Bradford Rice J; White A; Lopez A; Galebach P; Schepman P; Popelar B; Philbin M
J Med Econ; 2016 Jul; 19(7):649-54. PubMed ID: 26850074
[TBL] [Abstract][Full Text] [Related]
3. Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year Study of National Inpatient Sample.
Ungprasert P; Wannarong T; Cheungpasitporn W; Wijarnpreecha K; Thongprayoon C; Kroner PT
Joint Bone Spine; 2020 Jul; 87(4):327-330. PubMed ID: 32184181
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
Hozumi H; Fujisawa T; Nakashima R; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Inui N; Nakamura Y; Mimori T; Suda T
J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and incidence of polymyositis and dermatomyositis in Japan.
Ohta A; Nagai M; Nishina M; Tomimitsu H; Kohsaka H
Mod Rheumatol; 2014 May; 24(3):477-80. PubMed ID: 24252012
[TBL] [Abstract][Full Text] [Related]
7. Polymyositis/dermatomyositis readmissions: analysis of the nationwide readmission database.
Idolor O; Edigin E; Hino C; He E; Rao J; Ugoh AC; Onobraigho P; Omoike E; Okpujie V; Ezeafulukwe CJ; Eseaton PO; Manadan A; Downey C
Clin Rheumatol; 2023 Oct; 42(10):2833-2839. PubMed ID: 37407906
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.
Kuwana M; Wakasugi N; Furuya T; Uno S; Suda T
J Rheumatol; 2022 Jul; 49(7):707-718. PubMed ID: 35428708
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.
Motomura K; Yamashita H; Yamada S; Takahashi Y; Kaneko H
Rheumatol Int; 2019 Oct; 39(10):1733-1739. PubMed ID: 31444556
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan.
Hu Q; Huang KC; Goh CH; Tsuchiya Y; Liu Y; Qiu H
Sci Rep; 2023 Oct; 13(1):17172. PubMed ID: 37821555
[TBL] [Abstract][Full Text] [Related]
11. Ventricular arrhythmia predicts poor outcome in polymyositis/dermatomyositis with myocardial involvement.
Huang Y; Liu H; Wu C; Fang L; Fang Q; Wang Q; Fei Y; Guo X; Zhang S
Rheumatology (Oxford); 2021 Aug; 60(8):3809-3816. PubMed ID: 33369674
[TBL] [Abstract][Full Text] [Related]
12. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.
Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N
Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061
[TBL] [Abstract][Full Text] [Related]
13. Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysis.
Wattanakamolkul K; Nakayama Y
J Med Econ; 2022; 25(1):870-879. PubMed ID: 35703058
[TBL] [Abstract][Full Text] [Related]
14. Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.
Lee CW; Muo CH; Liang JA; Sung FC; Hsu CY; Kao CH
Endocrine; 2016 Apr; 52(1):86-92. PubMed ID: 26429781
[TBL] [Abstract][Full Text] [Related]
15. Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak General Hospital.
Teh CL; Wong JS; Soo HH
Rheumatol Int; 2012 Jan; 32(1):265-8. PubMed ID: 21243497
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological profile of dermatomyositis and polymyositis: a study conducted in the Department of Rheumatology in Marrakech].
Errafia S; Mougui A; Bouchti IE
Pan Afr Med J; 2021; 38():101. PubMed ID: 33889267
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.
Tomimitsu H; Ohta A; Nagai M; Nishina M; Ishihara S; Kohsaka H
Mod Rheumatol; 2016; 26(3):398-402. PubMed ID: 26375202
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020.
Sun KY; Fan Y; Wang YX; Zhong YJ; Wang GF
Semin Arthritis Rheum; 2021 Feb; 51(1):175-191. PubMed ID: 33383294
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical course of polymyositis and dermatomyositis: a follow-up study in Tokushima University Hospital.
Tani K; Tomioka R; Sato K; Furukawa C; Nakajima T; Toyota Y; Shimizu T; Nakayama M; Miyata J; Kishi J; Sone S
J Med Invest; 2007 Aug; 54(3-4):295-302. PubMed ID: 17878679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
